nodes	percent_of_prediction	percent_of_DWPC	metapath
Leflunomide—PTK2B—epilepsy syndrome	0.395	0.811	CbGaD
Leflunomide—ABCG2—epilepsy syndrome	0.0921	0.189	CbGaD
Leflunomide—CYP2C9—Trimethadione—epilepsy syndrome	0.0256	0.105	CbGbCtD
Leflunomide—CYP2C9—Fosphenytoin—epilepsy syndrome	0.0241	0.0983	CbGbCtD
Leflunomide—CYP1A2—Carbamazepine—epilepsy syndrome	0.0192	0.0784	CbGbCtD
Leflunomide—CYP1A2—Primidone—epilepsy syndrome	0.0179	0.0732	CbGbCtD
Leflunomide—CYP2C9—Carbamazepine—epilepsy syndrome	0.0173	0.0706	CbGbCtD
Leflunomide—CYP2C9—Primidone—epilepsy syndrome	0.0161	0.0659	CbGbCtD
Leflunomide—CYP1A2—Propofol—epilepsy syndrome	0.016	0.0656	CbGbCtD
Leflunomide—CYP2C9—Phenytoin—epilepsy syndrome	0.0155	0.0633	CbGbCtD
Leflunomide—CYP1A2—Phenobarbital—epilepsy syndrome	0.0153	0.0627	CbGbCtD
Leflunomide—CYP1A2—Diazepam—epilepsy syndrome	0.0145	0.0594	CbGbCtD
Leflunomide—CYP2C9—Propofol—epilepsy syndrome	0.0145	0.0591	CbGbCtD
Leflunomide—CYP2C9—Phenobarbital—epilepsy syndrome	0.0138	0.0565	CbGbCtD
Leflunomide—CYP2C9—Diazepam—epilepsy syndrome	0.0131	0.0535	CbGbCtD
Leflunomide—CYP1A2—Valproic Acid—epilepsy syndrome	0.0115	0.0468	CbGbCtD
Leflunomide—CYP2C9—Valproic Acid—epilepsy syndrome	0.0103	0.0422	CbGbCtD
Leflunomide—PTK2B—forebrain—epilepsy syndrome	0.000841	0.0956	CbGeAlD
Leflunomide—PTK2B—telencephalon—epilepsy syndrome	0.000773	0.0879	CbGeAlD
Leflunomide—DHODH—head—epilepsy syndrome	0.00076	0.0864	CbGeAlD
Leflunomide—AHR—telencephalon—epilepsy syndrome	0.000636	0.0723	CbGeAlD
Leflunomide—DHODH—brain—epilepsy syndrome	0.000551	0.0626	CbGeAlD
Leflunomide—AHR—medulla oblongata—epilepsy syndrome	0.0005	0.0568	CbGeAlD
Leflunomide—PTK2B—head—epilepsy syndrome	0.000482	0.0547	CbGeAlD
Leflunomide—PTK2B—nervous system—epilepsy syndrome	0.000457	0.0519	CbGeAlD
Leflunomide—AHR—midbrain—epilepsy syndrome	0.000457	0.0519	CbGeAlD
Leflunomide—AHR—spinal cord—epilepsy syndrome	0.000445	0.0506	CbGeAlD
Leflunomide—PTK2B—central nervous system—epilepsy syndrome	0.00044	0.05	CbGeAlD
Leflunomide—PTK2B—cerebellum—epilepsy syndrome	0.00043	0.0488	CbGeAlD
Leflunomide—AHR—cerebellum—epilepsy syndrome	0.000353	0.0401	CbGeAlD
Leflunomide—PTK2B—brain—epilepsy syndrome	0.000349	0.0397	CbGeAlD
Leflunomide—AHR—brain—epilepsy syndrome	0.000287	0.0326	CbGeAlD
Leflunomide—ABCG2—telencephalon—epilepsy syndrome	0.000247	0.028	CbGeAlD
Leflunomide—ABCG2—medulla oblongata—epilepsy syndrome	0.000194	0.022	CbGeAlD
Leflunomide—ABCG2—midbrain—epilepsy syndrome	0.000177	0.0201	CbGeAlD
Leflunomide—ABCG2—spinal cord—epilepsy syndrome	0.000173	0.0196	CbGeAlD
Leflunomide—ABCG2—cerebellum—epilepsy syndrome	0.000137	0.0156	CbGeAlD
Leflunomide—ABCG2—brain—epilepsy syndrome	0.000111	0.0126	CbGeAlD
Leflunomide—Niflumic Acid—PTGS2—epilepsy syndrome	8.42e-05	1	CrCbGaD
Leflunomide—Cough—Pregabalin—epilepsy syndrome	3.69e-05	0.000201	CcSEcCtD
Leflunomide—Pruritus—Phenytoin—epilepsy syndrome	3.68e-05	0.000201	CcSEcCtD
Leflunomide—Connective tissue disorder—Topiramate—epilepsy syndrome	3.68e-05	0.000201	CcSEcCtD
Leflunomide—Nausea—Levetiracetam—epilepsy syndrome	3.68e-05	0.000201	CcSEcCtD
Leflunomide—Rash—Vigabatrin—epilepsy syndrome	3.68e-05	0.000201	CcSEcCtD
Leflunomide—Dizziness—Felbamate—epilepsy syndrome	3.67e-05	0.0002	CcSEcCtD
Leflunomide—Dermatitis—Vigabatrin—epilepsy syndrome	3.67e-05	0.0002	CcSEcCtD
Leflunomide—Urethral disorder—Topiramate—epilepsy syndrome	3.67e-05	0.0002	CcSEcCtD
Leflunomide—Pruritus—Oxcarbazepine—epilepsy syndrome	3.66e-05	0.0002	CcSEcCtD
Leflunomide—Hypersensitivity—Carbamazepine—epilepsy syndrome	3.66e-05	0.0002	CcSEcCtD
Leflunomide—Vision blurred—Gabapentin—epilepsy syndrome	3.65e-05	0.000199	CcSEcCtD
Leflunomide—Headache—Vigabatrin—epilepsy syndrome	3.65e-05	0.000199	CcSEcCtD
Leflunomide—Hypertension—Pregabalin—epilepsy syndrome	3.65e-05	0.000199	CcSEcCtD
Leflunomide—Vomiting—Diazepam—epilepsy syndrome	3.65e-05	0.000199	CcSEcCtD
Leflunomide—Anorexia—Valproic Acid—epilepsy syndrome	3.64e-05	0.000199	CcSEcCtD
Leflunomide—Rash—Diazepam—epilepsy syndrome	3.62e-05	0.000198	CcSEcCtD
Leflunomide—Dermatitis—Diazepam—epilepsy syndrome	3.62e-05	0.000197	CcSEcCtD
Leflunomide—Chest pain—Pregabalin—epilepsy syndrome	3.6e-05	0.000196	CcSEcCtD
Leflunomide—Arthralgia—Pregabalin—epilepsy syndrome	3.6e-05	0.000196	CcSEcCtD
Leflunomide—Myalgia—Pregabalin—epilepsy syndrome	3.6e-05	0.000196	CcSEcCtD
Leflunomide—Ill-defined disorder—Gabapentin—epilepsy syndrome	3.6e-05	0.000196	CcSEcCtD
Leflunomide—Dizziness—Zonisamide—epilepsy syndrome	3.6e-05	0.000196	CcSEcCtD
Leflunomide—Headache—Diazepam—epilepsy syndrome	3.6e-05	0.000196	CcSEcCtD
Leflunomide—Anxiety—Pregabalin—epilepsy syndrome	3.59e-05	0.000196	CcSEcCtD
Leflunomide—Diarrhoea—Clonazepam—epilepsy syndrome	3.59e-05	0.000196	CcSEcCtD
Leflunomide—Anaemia—Gabapentin—epilepsy syndrome	3.58e-05	0.000196	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	3.57e-05	0.000195	CcSEcCtD
Leflunomide—Hypotension—Valproic Acid—epilepsy syndrome	3.57e-05	0.000195	CcSEcCtD
Leflunomide—Asthenia—Carbamazepine—epilepsy syndrome	3.56e-05	0.000195	CcSEcCtD
Leflunomide—Diarrhoea—Phenytoin—epilepsy syndrome	3.56e-05	0.000194	CcSEcCtD
Leflunomide—Discomfort—Pregabalin—epilepsy syndrome	3.56e-05	0.000194	CcSEcCtD
Leflunomide—Nausea—Fosphenytoin—epilepsy syndrome	3.55e-05	0.000194	CcSEcCtD
Leflunomide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.54e-05	0.000193	CcSEcCtD
Leflunomide—Erythema multiforme—Topiramate—epilepsy syndrome	3.54e-05	0.000193	CcSEcCtD
Leflunomide—Angioedema—Gabapentin—epilepsy syndrome	3.54e-05	0.000193	CcSEcCtD
Leflunomide—Hypersensitivity—Lamotrigine—epilepsy syndrome	3.54e-05	0.000193	CcSEcCtD
Leflunomide—Vomiting—Felbamate—epilepsy syndrome	3.53e-05	0.000193	CcSEcCtD
Leflunomide—Dry mouth—Pregabalin—epilepsy syndrome	3.52e-05	0.000192	CcSEcCtD
Leflunomide—Pruritus—Carbamazepine—epilepsy syndrome	3.52e-05	0.000192	CcSEcCtD
Leflunomide—Rash—Felbamate—epilepsy syndrome	3.5e-05	0.000191	CcSEcCtD
Leflunomide—Eye disorder—Topiramate—epilepsy syndrome	3.5e-05	0.000191	CcSEcCtD
Leflunomide—Dermatitis—Felbamate—epilepsy syndrome	3.5e-05	0.000191	CcSEcCtD
Leflunomide—Malaise—Gabapentin—epilepsy syndrome	3.5e-05	0.000191	CcSEcCtD
Leflunomide—Vertigo—Gabapentin—epilepsy syndrome	3.48e-05	0.00019	CcSEcCtD
Leflunomide—Headache—Felbamate—epilepsy syndrome	3.48e-05	0.00019	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	3.48e-05	0.00019	CcSEcCtD
Leflunomide—Cardiac disorder—Topiramate—epilepsy syndrome	3.48e-05	0.00019	CcSEcCtD
Leflunomide—Leukopenia—Gabapentin—epilepsy syndrome	3.47e-05	0.000189	CcSEcCtD
Leflunomide—Dizziness—Clonazepam—epilepsy syndrome	3.47e-05	0.000189	CcSEcCtD
Leflunomide—Nausea—Vigabatrin—epilepsy syndrome	3.46e-05	0.000189	CcSEcCtD
Leflunomide—Vomiting—Zonisamide—epilepsy syndrome	3.46e-05	0.000189	CcSEcCtD
Leflunomide—Insomnia—Valproic Acid—epilepsy syndrome	3.45e-05	0.000188	CcSEcCtD
Leflunomide—Anaphylactic shock—Pregabalin—epilepsy syndrome	3.45e-05	0.000188	CcSEcCtD
Leflunomide—Asthenia—Lamotrigine—epilepsy syndrome	3.45e-05	0.000188	CcSEcCtD
Leflunomide—Dizziness—Phenytoin—epilepsy syndrome	3.44e-05	0.000188	CcSEcCtD
Leflunomide—Rash—Zonisamide—epilepsy syndrome	3.43e-05	0.000187	CcSEcCtD
Leflunomide—Infection—Pregabalin—epilepsy syndrome	3.43e-05	0.000187	CcSEcCtD
Leflunomide—Paraesthesia—Valproic Acid—epilepsy syndrome	3.43e-05	0.000187	CcSEcCtD
Leflunomide—Palpitations—Gabapentin—epilepsy syndrome	3.43e-05	0.000187	CcSEcCtD
Leflunomide—Dermatitis—Zonisamide—epilepsy syndrome	3.43e-05	0.000187	CcSEcCtD
Leflunomide—Dizziness—Oxcarbazepine—epilepsy syndrome	3.42e-05	0.000187	CcSEcCtD
Leflunomide—Nausea—Diazepam—epilepsy syndrome	3.41e-05	0.000186	CcSEcCtD
Leflunomide—Headache—Zonisamide—epilepsy syndrome	3.41e-05	0.000186	CcSEcCtD
Leflunomide—Dyspnoea—Valproic Acid—epilepsy syndrome	3.4e-05	0.000186	CcSEcCtD
Leflunomide—Diarrhoea—Carbamazepine—epilepsy syndrome	3.4e-05	0.000186	CcSEcCtD
Leflunomide—Pruritus—Lamotrigine—epilepsy syndrome	3.4e-05	0.000185	CcSEcCtD
Leflunomide—Immune system disorder—Topiramate—epilepsy syndrome	3.38e-05	0.000185	CcSEcCtD
Leflunomide—Nervous system disorder—Pregabalin—epilepsy syndrome	3.38e-05	0.000185	CcSEcCtD
Leflunomide—Cough—Gabapentin—epilepsy syndrome	3.38e-05	0.000185	CcSEcCtD
Leflunomide—Thrombocytopenia—Pregabalin—epilepsy syndrome	3.38e-05	0.000184	CcSEcCtD
Leflunomide—Mediastinal disorder—Topiramate—epilepsy syndrome	3.38e-05	0.000184	CcSEcCtD
Leflunomide—Tachycardia—Pregabalin—epilepsy syndrome	3.37e-05	0.000184	CcSEcCtD
Leflunomide—Chills—Topiramate—epilepsy syndrome	3.36e-05	0.000183	CcSEcCtD
Leflunomide—Dyspepsia—Valproic Acid—epilepsy syndrome	3.36e-05	0.000183	CcSEcCtD
Leflunomide—Skin disorder—Pregabalin—epilepsy syndrome	3.35e-05	0.000183	CcSEcCtD
Leflunomide—Hypertension—Gabapentin—epilepsy syndrome	3.35e-05	0.000183	CcSEcCtD
Leflunomide—Hyperhidrosis—Pregabalin—epilepsy syndrome	3.33e-05	0.000182	CcSEcCtD
Leflunomide—Vomiting—Clonazepam—epilepsy syndrome	3.33e-05	0.000182	CcSEcCtD
Leflunomide—Decreased appetite—Valproic Acid—epilepsy syndrome	3.32e-05	0.000181	CcSEcCtD
Leflunomide—Alopecia—Topiramate—epilepsy syndrome	3.31e-05	0.000181	CcSEcCtD
Leflunomide—Vomiting—Phenytoin—epilepsy syndrome	3.31e-05	0.000181	CcSEcCtD
Leflunomide—Rash—Clonazepam—epilepsy syndrome	3.3e-05	0.00018	CcSEcCtD
Leflunomide—Dermatitis—Clonazepam—epilepsy syndrome	3.3e-05	0.00018	CcSEcCtD
Leflunomide—Myalgia—Gabapentin—epilepsy syndrome	3.3e-05	0.00018	CcSEcCtD
Leflunomide—Arthralgia—Gabapentin—epilepsy syndrome	3.3e-05	0.00018	CcSEcCtD
Leflunomide—Chest pain—Gabapentin—epilepsy syndrome	3.3e-05	0.00018	CcSEcCtD
Leflunomide—Nausea—Felbamate—epilepsy syndrome	3.3e-05	0.00018	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	3.29e-05	0.00018	CcSEcCtD
Leflunomide—Vomiting—Oxcarbazepine—epilepsy syndrome	3.29e-05	0.00018	CcSEcCtD
Leflunomide—Fatigue—Valproic Acid—epilepsy syndrome	3.29e-05	0.00018	CcSEcCtD
Leflunomide—Anxiety—Gabapentin—epilepsy syndrome	3.29e-05	0.000179	CcSEcCtD
Leflunomide—Anorexia—Pregabalin—epilepsy syndrome	3.29e-05	0.000179	CcSEcCtD
Leflunomide—Dizziness—Carbamazepine—epilepsy syndrome	3.29e-05	0.000179	CcSEcCtD
Leflunomide—Diarrhoea—Lamotrigine—epilepsy syndrome	3.29e-05	0.000179	CcSEcCtD
Leflunomide—Headache—Clonazepam—epilepsy syndrome	3.28e-05	0.000179	CcSEcCtD
Leflunomide—Rash—Phenytoin—epilepsy syndrome	3.28e-05	0.000179	CcSEcCtD
Leflunomide—Mental disorder—Topiramate—epilepsy syndrome	3.28e-05	0.000179	CcSEcCtD
Leflunomide—Dermatitis—Phenytoin—epilepsy syndrome	3.28e-05	0.000179	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	3.28e-05	0.000179	CcSEcCtD
Leflunomide—Rash—Oxcarbazepine—epilepsy syndrome	3.26e-05	0.000178	CcSEcCtD
Leflunomide—Pain—Valproic Acid—epilepsy syndrome	3.26e-05	0.000178	CcSEcCtD
Leflunomide—Constipation—Valproic Acid—epilepsy syndrome	3.26e-05	0.000178	CcSEcCtD
Leflunomide—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.26e-05	0.000178	CcSEcCtD
Leflunomide—Headache—Phenytoin—epilepsy syndrome	3.26e-05	0.000178	CcSEcCtD
Leflunomide—Malnutrition—Topiramate—epilepsy syndrome	3.26e-05	0.000178	CcSEcCtD
Leflunomide—Discomfort—Gabapentin—epilepsy syndrome	3.26e-05	0.000178	CcSEcCtD
Leflunomide—Headache—Oxcarbazepine—epilepsy syndrome	3.24e-05	0.000177	CcSEcCtD
Leflunomide—Nausea—Zonisamide—epilepsy syndrome	3.23e-05	0.000176	CcSEcCtD
Leflunomide—Dry mouth—Gabapentin—epilepsy syndrome	3.23e-05	0.000176	CcSEcCtD
Leflunomide—Hypotension—Pregabalin—epilepsy syndrome	3.22e-05	0.000176	CcSEcCtD
Leflunomide—Flatulence—Topiramate—epilepsy syndrome	3.21e-05	0.000175	CcSEcCtD
Leflunomide—Dysgeusia—Topiramate—epilepsy syndrome	3.19e-05	0.000174	CcSEcCtD
Leflunomide—Dizziness—Lamotrigine—epilepsy syndrome	3.18e-05	0.000173	CcSEcCtD
Leflunomide—Anaphylactic shock—Gabapentin—epilepsy syndrome	3.16e-05	0.000173	CcSEcCtD
Leflunomide—Vomiting—Carbamazepine—epilepsy syndrome	3.16e-05	0.000172	CcSEcCtD
Leflunomide—Back pain—Topiramate—epilepsy syndrome	3.15e-05	0.000172	CcSEcCtD
Leflunomide—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.14e-05	0.000172	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.14e-05	0.000172	CcSEcCtD
Leflunomide—Infection—Gabapentin—epilepsy syndrome	3.14e-05	0.000172	CcSEcCtD
Leflunomide—Muscle spasms—Topiramate—epilepsy syndrome	3.13e-05	0.000171	CcSEcCtD
Leflunomide—Rash—Carbamazepine—epilepsy syndrome	3.13e-05	0.000171	CcSEcCtD
Leflunomide—Dermatitis—Carbamazepine—epilepsy syndrome	3.13e-05	0.000171	CcSEcCtD
Leflunomide—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	3.12e-05	0.00017	CcSEcCtD
Leflunomide—Insomnia—Pregabalin—epilepsy syndrome	3.12e-05	0.00017	CcSEcCtD
Leflunomide—Nausea—Clonazepam—epilepsy syndrome	3.11e-05	0.00017	CcSEcCtD
Leflunomide—Headache—Carbamazepine—epilepsy syndrome	3.11e-05	0.00017	CcSEcCtD
Leflunomide—Nervous system disorder—Gabapentin—epilepsy syndrome	3.1e-05	0.000169	CcSEcCtD
Leflunomide—Paraesthesia—Pregabalin—epilepsy syndrome	3.1e-05	0.000169	CcSEcCtD
Leflunomide—Thrombocytopenia—Gabapentin—epilepsy syndrome	3.1e-05	0.000169	CcSEcCtD
Leflunomide—Nausea—Phenytoin—epilepsy syndrome	3.09e-05	0.000169	CcSEcCtD
Leflunomide—Tachycardia—Gabapentin—epilepsy syndrome	3.09e-05	0.000169	CcSEcCtD
Leflunomide—Dyspnoea—Pregabalin—epilepsy syndrome	3.08e-05	0.000168	CcSEcCtD
Leflunomide—Nausea—Oxcarbazepine—epilepsy syndrome	3.08e-05	0.000168	CcSEcCtD
Leflunomide—Vision blurred—Topiramate—epilepsy syndrome	3.07e-05	0.000168	CcSEcCtD
Leflunomide—Skin disorder—Gabapentin—epilepsy syndrome	3.07e-05	0.000168	CcSEcCtD
Leflunomide—Hyperhidrosis—Gabapentin—epilepsy syndrome	3.06e-05	0.000167	CcSEcCtD
Leflunomide—Vomiting—Lamotrigine—epilepsy syndrome	3.05e-05	0.000167	CcSEcCtD
Leflunomide—Urticaria—Valproic Acid—epilepsy syndrome	3.03e-05	0.000165	CcSEcCtD
Leflunomide—Rash—Lamotrigine—epilepsy syndrome	3.03e-05	0.000165	CcSEcCtD
Leflunomide—Ill-defined disorder—Topiramate—epilepsy syndrome	3.03e-05	0.000165	CcSEcCtD
Leflunomide—Dermatitis—Lamotrigine—epilepsy syndrome	3.02e-05	0.000165	CcSEcCtD
Leflunomide—Body temperature increased—Valproic Acid—epilepsy syndrome	3.02e-05	0.000165	CcSEcCtD
Leflunomide—Abdominal pain—Valproic Acid—epilepsy syndrome	3.02e-05	0.000165	CcSEcCtD
Leflunomide—Anorexia—Gabapentin—epilepsy syndrome	3.02e-05	0.000165	CcSEcCtD
Leflunomide—Anaemia—Topiramate—epilepsy syndrome	3.01e-05	0.000165	CcSEcCtD
Leflunomide—Headache—Lamotrigine—epilepsy syndrome	3.01e-05	0.000164	CcSEcCtD
Leflunomide—Decreased appetite—Pregabalin—epilepsy syndrome	3e-05	0.000164	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.98e-05	0.000163	CcSEcCtD
Leflunomide—Fatigue—Pregabalin—epilepsy syndrome	2.97e-05	0.000162	CcSEcCtD
Leflunomide—Hypotension—Gabapentin—epilepsy syndrome	2.96e-05	0.000161	CcSEcCtD
Leflunomide—Nausea—Carbamazepine—epilepsy syndrome	2.95e-05	0.000161	CcSEcCtD
Leflunomide—Pain—Pregabalin—epilepsy syndrome	2.95e-05	0.000161	CcSEcCtD
Leflunomide—Constipation—Pregabalin—epilepsy syndrome	2.95e-05	0.000161	CcSEcCtD
Leflunomide—Malaise—Topiramate—epilepsy syndrome	2.94e-05	0.000161	CcSEcCtD
Leflunomide—Vertigo—Topiramate—epilepsy syndrome	2.93e-05	0.00016	CcSEcCtD
Leflunomide—Leukopenia—Topiramate—epilepsy syndrome	2.92e-05	0.000159	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	2.88e-05	0.000157	CcSEcCtD
Leflunomide—Palpitations—Topiramate—epilepsy syndrome	2.88e-05	0.000157	CcSEcCtD
Leflunomide—Insomnia—Gabapentin—epilepsy syndrome	2.86e-05	0.000156	CcSEcCtD
Leflunomide—Nausea—Lamotrigine—epilepsy syndrome	2.85e-05	0.000156	CcSEcCtD
Leflunomide—Cough—Topiramate—epilepsy syndrome	2.85e-05	0.000155	CcSEcCtD
Leflunomide—Feeling abnormal—Pregabalin—epilepsy syndrome	2.84e-05	0.000155	CcSEcCtD
Leflunomide—Paraesthesia—Gabapentin—epilepsy syndrome	2.84e-05	0.000155	CcSEcCtD
Leflunomide—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.82e-05	0.000154	CcSEcCtD
Leflunomide—Dyspnoea—Gabapentin—epilepsy syndrome	2.82e-05	0.000154	CcSEcCtD
Leflunomide—Hypertension—Topiramate—epilepsy syndrome	2.82e-05	0.000154	CcSEcCtD
Leflunomide—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.81e-05	0.000153	CcSEcCtD
Leflunomide—Dyspepsia—Gabapentin—epilepsy syndrome	2.78e-05	0.000152	CcSEcCtD
Leflunomide—Chest pain—Topiramate—epilepsy syndrome	2.78e-05	0.000152	CcSEcCtD
Leflunomide—Myalgia—Topiramate—epilepsy syndrome	2.78e-05	0.000152	CcSEcCtD
Leflunomide—Arthralgia—Topiramate—epilepsy syndrome	2.78e-05	0.000152	CcSEcCtD
Leflunomide—Anxiety—Topiramate—epilepsy syndrome	2.77e-05	0.000151	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	2.76e-05	0.00015	CcSEcCtD
Leflunomide—Decreased appetite—Gabapentin—epilepsy syndrome	2.75e-05	0.00015	CcSEcCtD
Leflunomide—Discomfort—Topiramate—epilepsy syndrome	2.74e-05	0.00015	CcSEcCtD
Leflunomide—Urticaria—Pregabalin—epilepsy syndrome	2.74e-05	0.00015	CcSEcCtD
Leflunomide—Asthenia—Valproic Acid—epilepsy syndrome	2.74e-05	0.000149	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.73e-05	0.000149	CcSEcCtD
Leflunomide—Fatigue—Gabapentin—epilepsy syndrome	2.73e-05	0.000149	CcSEcCtD
Leflunomide—Abdominal pain—Pregabalin—epilepsy syndrome	2.73e-05	0.000149	CcSEcCtD
Leflunomide—Body temperature increased—Pregabalin—epilepsy syndrome	2.73e-05	0.000149	CcSEcCtD
Leflunomide—Dry mouth—Topiramate—epilepsy syndrome	2.71e-05	0.000148	CcSEcCtD
Leflunomide—Pain—Gabapentin—epilepsy syndrome	2.7e-05	0.000148	CcSEcCtD
Leflunomide—Constipation—Gabapentin—epilepsy syndrome	2.7e-05	0.000148	CcSEcCtD
Leflunomide—Pruritus—Valproic Acid—epilepsy syndrome	2.7e-05	0.000147	CcSEcCtD
Leflunomide—Infection—Topiramate—epilepsy syndrome	2.64e-05	0.000144	CcSEcCtD
Leflunomide—Diarrhoea—Valproic Acid—epilepsy syndrome	2.61e-05	0.000143	CcSEcCtD
Leflunomide—Nervous system disorder—Topiramate—epilepsy syndrome	2.61e-05	0.000142	CcSEcCtD
Leflunomide—Feeling abnormal—Gabapentin—epilepsy syndrome	2.61e-05	0.000142	CcSEcCtD
Leflunomide—Thrombocytopenia—Topiramate—epilepsy syndrome	2.61e-05	0.000142	CcSEcCtD
Leflunomide—Tachycardia—Topiramate—epilepsy syndrome	2.6e-05	0.000142	CcSEcCtD
Leflunomide—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.59e-05	0.000141	CcSEcCtD
Leflunomide—Skin disorder—Topiramate—epilepsy syndrome	2.58e-05	0.000141	CcSEcCtD
Leflunomide—Hyperhidrosis—Topiramate—epilepsy syndrome	2.57e-05	0.00014	CcSEcCtD
Leflunomide—Hypersensitivity—Pregabalin—epilepsy syndrome	2.54e-05	0.000139	CcSEcCtD
Leflunomide—Anorexia—Topiramate—epilepsy syndrome	2.54e-05	0.000138	CcSEcCtD
Leflunomide—Dizziness—Valproic Acid—epilepsy syndrome	2.52e-05	0.000138	CcSEcCtD
Leflunomide—Urticaria—Gabapentin—epilepsy syndrome	2.51e-05	0.000137	CcSEcCtD
Leflunomide—Body temperature increased—Gabapentin—epilepsy syndrome	2.5e-05	0.000136	CcSEcCtD
Leflunomide—Abdominal pain—Gabapentin—epilepsy syndrome	2.5e-05	0.000136	CcSEcCtD
Leflunomide—Hypotension—Topiramate—epilepsy syndrome	2.49e-05	0.000136	CcSEcCtD
Leflunomide—Asthenia—Pregabalin—epilepsy syndrome	2.47e-05	0.000135	CcSEcCtD
Leflunomide—Pruritus—Pregabalin—epilepsy syndrome	2.44e-05	0.000133	CcSEcCtD
Leflunomide—Vomiting—Valproic Acid—epilepsy syndrome	2.43e-05	0.000132	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.42e-05	0.000132	CcSEcCtD
Leflunomide—Insomnia—Topiramate—epilepsy syndrome	2.41e-05	0.000131	CcSEcCtD
Leflunomide—Rash—Valproic Acid—epilepsy syndrome	2.41e-05	0.000131	CcSEcCtD
Leflunomide—Dermatitis—Valproic Acid—epilepsy syndrome	2.4e-05	0.000131	CcSEcCtD
Leflunomide—Headache—Valproic Acid—epilepsy syndrome	2.39e-05	0.00013	CcSEcCtD
Leflunomide—Paraesthesia—Topiramate—epilepsy syndrome	2.39e-05	0.00013	CcSEcCtD
Leflunomide—Dyspnoea—Topiramate—epilepsy syndrome	2.37e-05	0.00013	CcSEcCtD
Leflunomide—Diarrhoea—Pregabalin—epilepsy syndrome	2.36e-05	0.000129	CcSEcCtD
Leflunomide—Dyspepsia—Topiramate—epilepsy syndrome	2.34e-05	0.000128	CcSEcCtD
Leflunomide—Hypersensitivity—Gabapentin—epilepsy syndrome	2.33e-05	0.000127	CcSEcCtD
Leflunomide—Decreased appetite—Topiramate—epilepsy syndrome	2.31e-05	0.000126	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.3e-05	0.000125	CcSEcCtD
Leflunomide—Fatigue—Topiramate—epilepsy syndrome	2.29e-05	0.000125	CcSEcCtD
Leflunomide—Dizziness—Pregabalin—epilepsy syndrome	2.28e-05	0.000125	CcSEcCtD
Leflunomide—Constipation—Topiramate—epilepsy syndrome	2.28e-05	0.000124	CcSEcCtD
Leflunomide—Pain—Topiramate—epilepsy syndrome	2.28e-05	0.000124	CcSEcCtD
Leflunomide—Asthenia—Gabapentin—epilepsy syndrome	2.27e-05	0.000124	CcSEcCtD
Leflunomide—Nausea—Valproic Acid—epilepsy syndrome	2.27e-05	0.000124	CcSEcCtD
Leflunomide—Pruritus—Gabapentin—epilepsy syndrome	2.24e-05	0.000122	CcSEcCtD
Leflunomide—Vomiting—Pregabalin—epilepsy syndrome	2.19e-05	0.00012	CcSEcCtD
Leflunomide—Feeling abnormal—Topiramate—epilepsy syndrome	2.19e-05	0.00012	CcSEcCtD
Leflunomide—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.18e-05	0.000119	CcSEcCtD
Leflunomide—Rash—Pregabalin—epilepsy syndrome	2.18e-05	0.000119	CcSEcCtD
Leflunomide—Dermatitis—Pregabalin—epilepsy syndrome	2.17e-05	0.000119	CcSEcCtD
Leflunomide—Diarrhoea—Gabapentin—epilepsy syndrome	2.16e-05	0.000118	CcSEcCtD
Leflunomide—Headache—Pregabalin—epilepsy syndrome	2.16e-05	0.000118	CcSEcCtD
Leflunomide—Urticaria—Topiramate—epilepsy syndrome	2.11e-05	0.000115	CcSEcCtD
Leflunomide—Abdominal pain—Topiramate—epilepsy syndrome	2.1e-05	0.000115	CcSEcCtD
Leflunomide—Body temperature increased—Topiramate—epilepsy syndrome	2.1e-05	0.000115	CcSEcCtD
Leflunomide—Dizziness—Gabapentin—epilepsy syndrome	2.09e-05	0.000114	CcSEcCtD
Leflunomide—Nausea—Pregabalin—epilepsy syndrome	2.05e-05	0.000112	CcSEcCtD
Leflunomide—Vomiting—Gabapentin—epilepsy syndrome	2.01e-05	0.00011	CcSEcCtD
Leflunomide—Rash—Gabapentin—epilepsy syndrome	1.99e-05	0.000109	CcSEcCtD
Leflunomide—Dermatitis—Gabapentin—epilepsy syndrome	1.99e-05	0.000109	CcSEcCtD
Leflunomide—Headache—Gabapentin—epilepsy syndrome	1.98e-05	0.000108	CcSEcCtD
Leflunomide—Hypersensitivity—Topiramate—epilepsy syndrome	1.96e-05	0.000107	CcSEcCtD
Leflunomide—Asthenia—Topiramate—epilepsy syndrome	1.91e-05	0.000104	CcSEcCtD
Leflunomide—Pruritus—Topiramate—epilepsy syndrome	1.88e-05	0.000103	CcSEcCtD
Leflunomide—Nausea—Gabapentin—epilepsy syndrome	1.88e-05	0.000103	CcSEcCtD
Leflunomide—Diarrhoea—Topiramate—epilepsy syndrome	1.82e-05	9.94e-05	CcSEcCtD
Leflunomide—Dizziness—Topiramate—epilepsy syndrome	1.76e-05	9.61e-05	CcSEcCtD
Leflunomide—Vomiting—Topiramate—epilepsy syndrome	1.69e-05	9.24e-05	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—CCR3—epilepsy syndrome	1.68e-05	0.00022	CbGpPWpGaD
Leflunomide—Rash—Topiramate—epilepsy syndrome	1.68e-05	9.16e-05	CcSEcCtD
Leflunomide—Dermatitis—Topiramate—epilepsy syndrome	1.68e-05	9.15e-05	CcSEcCtD
Leflunomide—ABCG2—Metabolism—ASAH1—epilepsy syndrome	1.67e-05	0.000219	CbGpPWpGaD
Leflunomide—Headache—Topiramate—epilepsy syndrome	1.67e-05	9.1e-05	CcSEcCtD
Leflunomide—ABCG2—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1.65e-05	0.000216	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NPY—epilepsy syndrome	1.64e-05	0.000214	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—ATP2A2—epilepsy syndrome	1.64e-05	0.000214	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—STXBP1—epilepsy syndrome	1.63e-05	0.000213	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	1.62e-05	0.000212	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—NT5E—epilepsy syndrome	1.59e-05	0.000207	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ALAD—epilepsy syndrome	1.59e-05	0.000207	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL18—epilepsy syndrome	1.58e-05	0.000207	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—HSPB1—epilepsy syndrome	1.58e-05	0.000207	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—OXT—epilepsy syndrome	1.58e-05	0.000207	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CCL3—epilepsy syndrome	1.58e-05	0.000207	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CXCL2—epilepsy syndrome	1.58e-05	0.000207	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CRH—epilepsy syndrome	1.58e-05	0.000207	CbGpPWpGaD
Leflunomide—Nausea—Topiramate—epilepsy syndrome	1.58e-05	8.63e-05	CcSEcCtD
Leflunomide—ABCG2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.58e-05	0.000206	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CA13—epilepsy syndrome	1.57e-05	0.000206	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—epilepsy syndrome	1.56e-05	0.000204	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—epilepsy syndrome	1.56e-05	0.000204	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—FYN—epilepsy syndrome	1.54e-05	0.000202	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—MEF2C—epilepsy syndrome	1.53e-05	0.0002	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CACNA1A—epilepsy syndrome	1.51e-05	0.000198	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ALDH7A1—epilepsy syndrome	1.51e-05	0.000198	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—YWHAZ—epilepsy syndrome	1.48e-05	0.000194	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	1.48e-05	0.000194	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ST3GAL3—epilepsy syndrome	1.48e-05	0.000194	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—TSC1—epilepsy syndrome	1.47e-05	0.000192	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ADSL—epilepsy syndrome	1.45e-05	0.00019	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CCR2—epilepsy syndrome	1.43e-05	0.000187	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NTRK2—epilepsy syndrome	1.43e-05	0.000187	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—SST—epilepsy syndrome	1.43e-05	0.000187	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GLUL—epilepsy syndrome	1.42e-05	0.000186	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—DUSP6—epilepsy syndrome	1.42e-05	0.000185	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—ADRA2A—epilepsy syndrome	1.4e-05	0.000183	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CACNA1D—epilepsy syndrome	1.4e-05	0.000183	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GLUD1—epilepsy syndrome	1.4e-05	0.000182	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PDXK—epilepsy syndrome	1.4e-05	0.000182	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CERS1—epilepsy syndrome	1.4e-05	0.000182	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—FAR1—epilepsy syndrome	1.4e-05	0.000182	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—L2HGDH—epilepsy syndrome	1.4e-05	0.000182	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ADK—epilepsy syndrome	1.4e-05	0.000182	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PLAT—epilepsy syndrome	1.39e-05	0.000182	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CXCL12—epilepsy syndrome	1.34e-05	0.000176	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—BDKRB2—epilepsy syndrome	1.34e-05	0.000176	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CRP—epilepsy syndrome	1.33e-05	0.000173	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—TSC2—epilepsy syndrome	1.33e-05	0.000173	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—JUNB—epilepsy syndrome	1.32e-05	0.000173	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CNR1—epilepsy syndrome	1.32e-05	0.000173	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PLCB1—epilepsy syndrome	1.32e-05	0.000172	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—TXNRD1—epilepsy syndrome	1.31e-05	0.000171	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.3e-05	0.00017	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—HTR7—epilepsy syndrome	1.29e-05	0.000168	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.29e-05	0.000168	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PNPO—epilepsy syndrome	1.28e-05	0.000167	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—EPM2A—epilepsy syndrome	1.28e-05	0.000167	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GAMT—epilepsy syndrome	1.28e-05	0.000167	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—NHLRC1—epilepsy syndrome	1.28e-05	0.000167	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—AQP1—epilepsy syndrome	1.27e-05	0.000166	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	1.27e-05	0.000166	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—HBEGF—epilepsy syndrome	1.25e-05	0.000163	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.25e-05	0.000163	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—AKT3—epilepsy syndrome	1.23e-05	0.00016	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—PRKCB—epilepsy syndrome	1.22e-05	0.00016	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL6ST—epilepsy syndrome	1.22e-05	0.000159	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—ADAM10—epilepsy syndrome	1.2e-05	0.000157	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—L2HGDH—epilepsy syndrome	1.19e-05	0.000156	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GLUD1—epilepsy syndrome	1.19e-05	0.000156	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—FAR1—epilepsy syndrome	1.19e-05	0.000156	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CERS1—epilepsy syndrome	1.19e-05	0.000156	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PDXK—epilepsy syndrome	1.19e-05	0.000156	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ADK—epilepsy syndrome	1.19e-05	0.000156	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—QDPR—epilepsy syndrome	1.19e-05	0.000155	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CA4—epilepsy syndrome	1.19e-05	0.000155	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—POMC—epilepsy syndrome	1.18e-05	0.000155	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CHRM3—epilepsy syndrome	1.15e-05	0.00015	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—KCNJ11—epilepsy syndrome	1.15e-05	0.00015	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—S100B—epilepsy syndrome	1.13e-05	0.000148	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—SOCS3—epilepsy syndrome	1.12e-05	0.000147	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CDC42—epilepsy syndrome	1.12e-05	0.000146	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—FOS—epilepsy syndrome	1.12e-05	0.000146	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—COX3—epilepsy syndrome	1.12e-05	0.000146	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—NHLRC1—epilepsy syndrome	1.09e-05	0.000143	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PNPO—epilepsy syndrome	1.09e-05	0.000143	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—EPM2A—epilepsy syndrome	1.09e-05	0.000143	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GAMT—epilepsy syndrome	1.09e-05	0.000143	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CASP8—epilepsy syndrome	1.09e-05	0.000143	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—AVP—epilepsy syndrome	1.08e-05	0.000142	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—KCNB1—epilepsy syndrome	1.06e-05	0.000138	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—SLCO1A2—epilepsy syndrome	1.06e-05	0.000138	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CACNA2D2—epilepsy syndrome	1.06e-05	0.000138	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PFKL—epilepsy syndrome	1.06e-05	0.000138	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—SLC6A8—epilepsy syndrome	1.06e-05	0.000138	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.03e-05	0.000135	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.03e-05	0.000134	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—HES1—epilepsy syndrome	1.03e-05	0.000134	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CA4—epilepsy syndrome	1.01e-05	0.000133	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—QDPR—epilepsy syndrome	1.01e-05	0.000133	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—POMC—epilepsy syndrome	1.01e-05	0.000132	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—FYN—epilepsy syndrome	9.97e-06	0.00013	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—H2AFX—epilepsy syndrome	9.93e-06	0.00013	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—AKT1—epilepsy syndrome	9.93e-06	0.00013	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—MEF2C—epilepsy syndrome	9.91e-06	0.00013	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—FGF2—epilepsy syndrome	9.85e-06	0.000129	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ATIC—epilepsy syndrome	9.67e-06	0.000126	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—UPB1—epilepsy syndrome	9.67e-06	0.000126	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—NEU1—epilepsy syndrome	9.67e-06	0.000126	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—YWHAZ—epilepsy syndrome	9.58e-06	0.000125	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—COX3—epilepsy syndrome	9.53e-06	0.000125	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NGF—epilepsy syndrome	9.48e-06	0.000124	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—BCL2—epilepsy syndrome	9.36e-06	0.000122	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	9.31e-06	0.000122	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CCR5—epilepsy syndrome	9.22e-06	0.00012	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—RELA—epilepsy syndrome	9.15e-06	0.00012	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CYP2C19—epilepsy syndrome	9.11e-06	0.000119	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CYP11A1—epilepsy syndrome	9.06e-06	0.000118	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PFKL—epilepsy syndrome	9.04e-06	0.000118	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—SLCO1A2—epilepsy syndrome	9.04e-06	0.000118	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CACNA2D2—epilepsy syndrome	9.04e-06	0.000118	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—KCNB1—epilepsy syndrome	9.04e-06	0.000118	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—SLC6A8—epilepsy syndrome	9.04e-06	0.000118	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—HTR2A—epilepsy syndrome	9.02e-06	0.000118	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	8.99e-06	0.000118	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GBE1—epilepsy syndrome	8.99e-06	0.000118	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—MTOR—epilepsy syndrome	8.97e-06	0.000117	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	8.83e-06	0.000115	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	8.79e-06	0.000115	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	8.78e-06	0.000115	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—TSC2—epilepsy syndrome	8.57e-06	0.000112	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—AGT—epilepsy syndrome	8.56e-06	0.000112	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	8.46e-06	0.000111	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—APOE—epilepsy syndrome	8.39e-06	0.00011	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL1B—epilepsy syndrome	8.27e-06	0.000108	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—UPB1—epilepsy syndrome	8.27e-06	0.000108	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ATIC—epilepsy syndrome	8.27e-06	0.000108	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—NEU1—epilepsy syndrome	8.27e-06	0.000108	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	8.23e-06	0.000108	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—KDR—epilepsy syndrome	8.22e-06	0.000107	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CYP2D6—epilepsy syndrome	8.18e-06	0.000107	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—NT5E—epilepsy syndrome	8.02e-06	0.000105	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ALAD—epilepsy syndrome	8.02e-06	0.000105	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—JUN—epilepsy syndrome	8.01e-06	0.000105	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—HSD17B4—epilepsy syndrome	7.96e-06	0.000104	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PRKCB—epilepsy syndrome	7.91e-06	0.000103	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IL6ST—epilepsy syndrome	7.88e-06	0.000103	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	7.8e-06	0.000102	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ADRA2A—epilepsy syndrome	7.78e-06	0.000102	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—BCHE—epilepsy syndrome	7.75e-06	0.000101	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GBE1—epilepsy syndrome	7.68e-06	0.0001	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	7.68e-06	0.0001	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	7.65e-06	0.0001	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	7.65e-06	0.0001	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	7.51e-06	9.82e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	7.48e-06	9.78e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—SLC2A1—epilepsy syndrome	7.39e-06	9.66e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ADSL—epilepsy syndrome	7.33e-06	9.58e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PLCB1—epilepsy syndrome	7.31e-06	9.56e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—TH—epilepsy syndrome	7.29e-06	9.53e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	7.23e-06	9.44e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—POMC—epilepsy syndrome	7.2e-06	9.42e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GLUL—epilepsy syndrome	7.19e-06	9.4e-05	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—SRC—epilepsy syndrome	7.19e-06	9.4e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	7.06e-06	9.22e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CCL2—epilepsy syndrome	7.05e-06	9.21e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	7.03e-06	9.19e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—NT5E—epilepsy syndrome	6.85e-06	8.95e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ALAD—epilepsy syndrome	6.85e-06	8.95e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	6.6e-06	8.63e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	6.53e-06	8.54e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	6.53e-06	8.54e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—AQP1—epilepsy syndrome	6.41e-06	8.38e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	6.39e-06	8.36e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—FGF2—epilepsy syndrome	6.37e-06	8.33e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ADSL—epilepsy syndrome	6.26e-06	8.19e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	6.15e-06	8.05e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GLUL—epilepsy syndrome	6.14e-06	8.03e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—HMOX1—epilepsy syndrome	6.08e-06	7.95e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	6.03e-06	7.88e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CAT—epilepsy syndrome	6e-06	7.84e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—RELA—epilepsy syndrome	5.91e-06	7.73e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ABCB1—epilepsy syndrome	5.84e-06	7.63e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—MTOR—epilepsy syndrome	5.8e-06	7.58e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	5.8e-06	7.58e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	5.8e-06	7.58e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	5.64e-06	7.37e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—AQP1—epilepsy syndrome	5.48e-06	7.16e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GPX1—epilepsy syndrome	5.43e-06	7.09e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.4e-06	7.05e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CASP3—epilepsy syndrome	5.33e-06	6.97e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.29e-06	6.91e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.26e-06	6.87e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—JUN—epilepsy syndrome	5.18e-06	6.77e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—MMP9—epilepsy syndrome	5.04e-06	6.59e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	4.95e-06	6.47e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	4.95e-06	6.47e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—AGT—epilepsy syndrome	4.76e-06	6.22e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	4.72e-06	6.18e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—APOE—epilepsy syndrome	4.66e-06	6.09e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—SRC—epilepsy syndrome	4.65e-06	6.07e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.61e-06	6.03e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	4.6e-06	6.02e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	4.58e-06	5.98e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.54e-06	5.94e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—VEGFA—epilepsy syndrome	4.53e-06	5.92e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.52e-06	5.91e-05	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—AKT1—epilepsy syndrome	4.47e-06	5.84e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.14e-06	5.41e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	4.13e-06	5.4e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	4.04e-06	5.28e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—POMC—epilepsy syndrome	4.01e-06	5.24e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	3.93e-06	5.14e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	3.93e-06	5.14e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—BCHE—epilepsy syndrome	3.91e-06	5.12e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	3.91e-06	5.11e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.88e-06	5.07e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	3.73e-06	4.88e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	3.69e-06	4.83e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—TH—epilepsy syndrome	3.68e-06	4.81e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ALB—epilepsy syndrome	3.65e-06	4.77e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.62e-06	4.74e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.54e-06	4.63e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	3.53e-06	4.61e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	3.36e-06	4.39e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—BCHE—epilepsy syndrome	3.35e-06	4.37e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PTGS2—epilepsy syndrome	3.19e-06	4.18e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	3.19e-06	4.17e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	3.16e-06	4.13e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—TH—epilepsy syndrome	3.15e-06	4.11e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.1e-06	4.05e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	3.07e-06	4.02e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CAT—epilepsy syndrome	3.03e-06	3.96e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	2.95e-06	3.85e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—AKT1—epilepsy syndrome	2.89e-06	3.78e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GPX1—epilepsy syndrome	2.74e-06	3.58e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	2.62e-06	3.43e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CAT—epilepsy syndrome	2.59e-06	3.39e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	2.52e-06	3.29e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—AGT—epilepsy syndrome	2.4e-06	3.14e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—APOE—epilepsy syndrome	2.35e-06	3.08e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GPX1—epilepsy syndrome	2.34e-06	3.06e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—AGT—epilepsy syndrome	2.05e-06	2.68e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—POMC—epilepsy syndrome	2.02e-06	2.64e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—APOE—epilepsy syndrome	2.01e-06	2.63e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ALB—epilepsy syndrome	1.84e-06	2.41e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—POMC—epilepsy syndrome	1.73e-06	2.26e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	1.61e-06	2.11e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—AKT1—epilepsy syndrome	1.61e-06	2.1e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ALB—epilepsy syndrome	1.58e-06	2.06e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	1.38e-06	1.8e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—AKT1—epilepsy syndrome	8.11e-07	1.06e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—AKT1—epilepsy syndrome	6.93e-07	9.06e-06	CbGpPWpGaD
